Atossa Therapeutics, Inc. (NASDAQ: ATOS) is a clinical-stage biopharmaceutical company focusing on breast cancer and other breast conditions.

Atossa Therapeutics, Inc. is a Seattle-based clinical-stage biopharmaceutical company developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. They believe that their innovative therapies and delivery methods can transform breast cancer treatment– with the goals of preventing breast cancer from developing in the first place, to increasing the odds of surviving for those who do develop this deadly disease. Learn more at www.atossatherapeutics.com

Presentation